| RS2464614456 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464623480 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464625113 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464633669 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Congenital myopathy 18, Congenital myopathy 18 |
| RS2464667395 |
IRF6
|
Health Risk |
Pathogenic |
Popliteal pterygium syndrome, Orofacial cleft 6 |
| RS2464667462 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464669962 |
IRF6
|
Health Risk |
Pathogenic |
IRF6-related condition, IRF6-related condition |
| RS2464670941 |
IRF6
|
Health Risk |
Likely pathogenic |
Popliteal pterygium syndrome, Van der Woude syndrome |
| RS2464671246 |
IRF6
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome, Van der Woude syndrome |
| RS2464680974 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464681125 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464682567 |
WDR26
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464682825 |
WDR26
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464683449 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464683464 |
IRF6
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464683525 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome 1, Van der Woude syndrome 1 |
| RS2464683585 |
IRF6
|
Health Risk |
Likely pathogenic |
— |
| RS2464683612 |
IRF6
|
Health Risk |
Likely pathogenic |
— |
| RS2464683620 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464683705 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464683838 |
IRF6
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464694698 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome, Popliteal pterygium syndrome |
| RS2464694798 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2464713052 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome |
| RS2464713058 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464713516 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464716295 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464716463 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464716697 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717019 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717157 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717162 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464717408 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717412 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717536 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464717567 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464720371 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464720512 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464720573 |
WDR26
|
Health Risk |
Pathogenic |
— |
| RS2464729 |
TRIM43
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2464737467 |
LAMB3
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2464739257 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2464743516 |
WDR26
|
Health Risk |
Pathogenic |
WDR26-related disorder, WDR26-related disorder |
| RS2464743563 |
WDR26
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464746180 |
LAMB3
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2464747078 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464747639 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464747702 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464747727 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464747975 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464748601 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464748620 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464748951 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464749701 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464750058 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464750210 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464750216 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2464750998 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464751124 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464751128 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464751272 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464751321 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464752319 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464752372 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS2464752397 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464752483 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464752503 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2464752818 |
LAMB3
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2464753039 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464753059 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Amelogenesis imperfecta type 1A |
| RS2464753233 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2464753342 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464757224 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS2464757569 |
TGFB2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2464757983 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 4 |
| RS2464758031 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464758865 |
LAMB3
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2464762597 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464763566 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2464763815 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS2464764083 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS2464764722 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2464764779 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS2464771286 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464771441 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2464771603 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464771760 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464772193 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464772258 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464772367 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464772723 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464772737 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464772765 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464782700 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2464784089 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2464784781 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464784840 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2464785059 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464785092 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464785255 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |